Rachel Cooney - Concepedia

Author

Rachel Cooney

University Hospitals Birmingham NHS Foundation Trust ORCID

Also Known As

Catherine Van Kemseke, Charlotte McNeill, Cooney R, Cooney, R, Cooney, Rachel, Jonas Halfvarson, Joseph Collum, Nigel J Trudgill, R Cooney, R. Cooney

195

Publications

Citations

H-Index

Concepts

All Affiliations

University Hospitals Birmingham NHS Foundation Trust Barts Health NHS Trust University of Birmingham Western General Hospital University of Oxford

About

Rachel Cooney is an author at University Hospitals Birmingham NHS Foundation Trust specializing in medicine, gastroenterology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	10	2K
2	Public Health	2	3	109
3	Natural Sciences	1	1	36
4	Allergy	1	1	72
5	Cell Biology	1	1	1K

Rachel Cooney

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation Rachel Cooney, J. T. BAKER, Oliver Brain, Nature Medicine Host ResponseCell AutophagyAutoimmune DiseaseNod2 Stimulation InducesAutophagy	2009	1K
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study Nicholas A. Kennedy, Graham Heap, Harry Green, The Lancet. Gastroenterology & hepatology InflammationActive Luminal CrohnAnti-tnf Treatment FailureImmunologyClinical Epidemiology	2019	655
HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease Aleksejs Sazonovs, Nicholas A. Kennedy, Loukas Moutsianas, Gastroenterology	2019	385
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic Nicholas A. Kennedy, Gareth‐Rhys Jones, Christopher A Lamb, Gut	2020	255
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial Nurulamin M Noor, James Lee, Simon Bond, The Lancet. Gastroenterology & hepatology	2024	229
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab. Nicholas A. Kennedy, James Goodhand, Claire Bewshea, Edinburgh Research Explorer (University of Edinburgh)	2021	163
Genetic Variants of Wnt Transcription Factor TCF-4 (TCF7L2) Putative Promoter Region Are Associated with Small Intestinal Crohn's Disease Maureen J. Koslowski, Irmgard Kübler, Mathias Chamaillard, PLoS ONE	2009	135
Outcome measurement in clinical trials for ulcerative colitis: towards standardisation Rachel Cooney, Bryan F. Warren, Douglas G. Altman, Trials	2007	126
Confirmation of the role of ATG16l1 as a Crohnʼs disease susceptibility gene Fraser Cummings, Rachel Cooney, Saad Pathan, Inflammatory Bowel Diseases	2007	122
Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study Neil Chanchlani, Simeng Lin, Claire Bewshea, The Lancet. Gastroenterology & hepatology	2024	108

Page 1